Objective: The purpose of this study was to determine if a perisurgical smoking cessation program reduces smoking-related postoperative complications in urogynecologic surgery. Study design: A review of patients that underwent pelvic reconstructive surgery from 1998 to 2003 was performed. All smokers underwent a perisurgical smoking cessation program of their choice for at least 1 month before surgery, and continued for 1 month after surgery. Complications unrelated to smoking (cystotomy, enterotomy, urethral obstruction, etc) were excluded in the smoking-potentiated complications. Problems considered to be potentiated by smoking were: wound, pulmonary, cardiac, and febrile morbidity. Results: Eight hundred eighty-seven patients were included. There were 233 smoker cessation patients (SC) and 654 nonsmokers (NS). The total number of complications in the SC group was 61 (61/233, 26%) compared with 172 (172/654, 29%) in the NS group: (chi-square, P = .97). When looking at smoking-potentiated complications only, there were 34 (34/61, 56%) patients in the SC group and 90 (90/172, 52%) in the NS group (chi-square, P = .75). Conclusion: There are no differences in smoking-potentiated complications between nonsmoking patients and patients who undergo a perisurgical smoking cessation program. Ó 2005 Elsevier Inc. All rights reserved.
Smoking is a major health risk, and is attributed to at least 20% of all deaths in developed countries. 1 Studies have shown that the incidence of postoperative complications in smokers is higher than in nonsmokers. [1] [2] [3] [4] [5] [6] [7] Many patients are encouraged to stop smoking before elective surgery, but many smoke up to the day of surgery. To date, there have been no reports on perisurgical smoking cessation and complications of urogynecologic surgery.
Postoperatively, pulmonary and wound complications are related to the mechanical and chemical properties of the tobacco and smoke. Mechanically, smoking impairs mucus transport by causing ciliary damage. Pulmonary macrophage function is impaired, increasing the risk for upper and lower respiratory tract infection.
Nicotine is a potent vasoconstrictor; increased arterial carbon monoxide reduces oxygen transport, and cyanide inhibits the mitochondrial oxidative metabolism. 1 These substances and others are considered to be contributing factors to wound complications and longer healing time. Studies show that smokers who cease within a few weeks of elective surgery have an increased risk of postoperative respiratory complications, and this may be attributed to a transient increase in sputum production. 1 A recent study found that healthy smokers have a higher rate of wound infections than neversmokers, yet 1 month of abstinence from smoking reduces wound infections to a level similar to neversmokers. 3 Additional studies have found that wound infection, skin flap necrosis, and epidermolysis is increased in smokers. 5 The purpose of this study was to determine if a short course of smoking cessation (4 weeks) decreases smoking-potentiated postoperative complications.
Material and methods
From March 1998 to December 2003, 2 prospective cohorts of patients having elective urogynecologic surgery were identified. The first cohort (SC) was patients who admitted to smoking on their initial history and physical exam. These patients were required to successfully participate in a smoking cessation program of their choice. Smoking cessation was for a minimum of 1 month before surgery and 1 month after surgery. Adherence to their program was determined by patient report. No specific method of smoking cessation was recommended, but patients were counseled regarding their options: nicotine supplementation, smoking cessation counseling, and/or medical therapy. Patients who claimed to have stopped smoking but for whom there was evidence to the contrary (smelled of smoke, still carried cigarettes, etc) were confronted; surgery was postponed until the patient complied. Patients who refused to undergo a smoking cessation program were directed elsewhere. The second cohort (NS) was nonsmokers having elective urogynecologic surgery.
Demographic, medical and surgical data, and postoperative complications were compared. Organ systems that were thought to be negatively impacted by smoking were: pulmonary (eg, pneumonia), skin (wound seroma, wound infection, wound hematoma, wound separation, and/or cellulitis of the surgical incision[s]), vascular (pulmonary embolus, phlebitis), cardiac (congestive heart failure, myocardial infarction), and postoperative febrile morbidity.
Preoperative medical clearance was obtained when indicated. All patients received a single dose of prophylactic antibiotics in the operating room, which consisted of a second-generation cephalosporin, or appropriate substitute based on drug allergies or other medical conditions. Patients who had a cystotomy had bladder drainage from 10 to 14 days. Once the catheter was removed, patients were given a 3-day course of oral antibiotics. Patients who did not sustain a bladder injury had their bladder catheters removed on the first postoperative day.
Both groups were subdivided into major and minor cases. A major case was defined as any entry into the abdominal cavity, any removal of a pelvic organ or foreign body, mobilizing the rectovaginal space, or entering the space of Retzius with mobilization of the bladder (eg, abdominal sacrocolpopexy, paravaginal repair, or Burch procedure). Procedures that traversed the space of Retzius but did not mobilize the bladder (eg, needle urethropexy) were classified as minor procedures. Other procedures in this classification were anterior colporrhaphy, perineorrhaphy, colpocleisis, vulvar biopsy, and vulvar wide local excision. There were no laparoscopic procedures.
The information was obtained from patient records on a computerized charting system (U3, .db med, llc, Greenville, SC). Categorical values were analyzed using chi-square test and continuous variable analyzed using Student t test (SAS, SAS Institute, Inc, Cary, NC). A P value of less than .05 was considered statically significant.
This study was approved by the Investigational Review Committee at Greenville Memorial Hospital, Greenville, SC (IRC #01-04-01).
Results
A total of eight hundred eighty-seven patients were identified. There were 233 smokers who underwent smoking cessation programs (SC) and 654 nonsmokers (NS). The average age of the SC group was 56 years (standard deviation [SD] 13.5), while the average age of the NS group was 61 years (SD 14.3; P ! .001). Gravidity among both groups was identical; 3.1 for each group (P = .82). Differences in parity were not significant (2.7 vs 2.6; P = .27). Nonsmokers weighed an average of 159 pounds (median 154 pounds), which was not different from the smoking group average weight of 163 pounds (median 160 pounds).
Medical problems were similar in both groups (average 3.1 per patient). A total of 410 procedures were performed in the SC group, and 1211 in the NS group; some patients had multiple procedures during 1 surgical episode, and others had multiple procedures and multiple surgical episodes. Table I shows the breakdown of surgeries, their classification of major and minor procedures, and incidence of mesh placement. The total number and comparison of complications in the SC and NS group are listed in Table II .
Comment
The data suggest that smoking cessation, even as short as 1 month before surgery, reduces overall postoperative complications in urogynecologic surgery. The reason for a 1-month cessation period was arbitrary, but one that the authors considered was feasible for the patient to accomplish. While a longer cessation may have been more beneficial, getting patients to adhere to this regimen may have been impractical.
The authors did not control for the type of smoking cessation, nor did they confirm smoking cessation by laboratory testing. Again, the authors felt it was more important to encourage patients to stop smoking by any method available, and not to endorse a particular smoking cessation program.
The most common smoking-potentiated postoperative event in both groups was a wound complication. A significant portion of postoperative wound care is managed as an outpatient, consuming physician and office resources until closure occurs.
As expected, pulmonary complications were increased in the smoking cessation group (2.6% CS, 0.9% NS), but this was not significant. Conversely, there were more mesh erosions in the nonsmoking group. This is due to the discordant number of patients at risk for mesh exposure. Eighty-four smokers had mesh placement with no erosions compared with 238 nonsmokers with 7 erosions, which is not statistically different.
Urinary tract infections have traditionally been the most common postoperative complication in gynecologic surgery; however, this was not the case in this urogynecology series. The most likely explanations for this are the rapid removal of the bladder catheter on the first postoperative day and the early ambulation of patients.
Limitations to our study include patient self-reported smoking cessation. This methodology has been used in other studies. 1 We performed this study on an intent-totreat basis, trusting the physician-patient relationship. Moreover, asking the patient without running a battery of tests more closely resembles clinical practice. There are additional variables, such as secondhand smoke, that cannot be controlled.
Smoking is self-inflicted and most urogynecologic surgeries are elective. Having patients stop smoking can be a perceived burden to them, yet this subjective complaint cannot surmount the objective difficulties of dealing with postoperative complications. Any intervention that reduces complications, improves outcomes, and enhances patient satisfaction should be endorsed. Further studies may consider these intangible factors into the final evaluation of smoking and risk for postoperative complications. 
